The FRISC II ECG substudy
|
|
- Rosalyn Owens
- 5 years ago
- Views:
Transcription
1 European Heart Journal (22) 23, doi:1.153/euhj , available online at on ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease The FRISC II ECG substudy E. Diderholm 1, B. Andrén 2, G. Frostfeldt 1, M. Genberg 2, T. Jernberg 1, B. Lagerqvist 1, B. Lindahl 1 and L. Wallentin 1 and the Fast Revascularization during InStability in Coronary artery disease (FRISC II) Investigators 1 Department of Cardiology and 2 Clinical Physiology, University Hospital, Uppsala, Sweden Background In unstable coronary artery disease, STsegment depression indicates a poor prognosis. We evaluated whether the effect of early revascularization and the extent of coronary lesions were related to ST-segment and T wave changes on admission. Methods and Results 2457 patients with unstable coronary artery disease were randomized to an early invasive strategy with coronary angiography/revascularization within 7 days or to a non-invasive strategy with coronary procedures only when symptoms or severe ischaemia recurred. ST depression was present in 1114 (45 5%) patients. In the invasive group, 45% of the patients with ST depression had three-vessel disease or left main stenosis compared with 22% if no ST-segment depression was present, P< 1. In patients with ST-segment depression the invasive strategy reduced death/myocardial infarction at 12 months from 18 2 to 12 %, RR 66 (95% CI 5 88) P= 4 while mortality was changed from 5 8 to 3 3%, P= 5. In patients without ST-segment depression the corresponding rates concerning death/myocardial infarction were 1 4 and 8 9, and for mortality 2 and 1 2% (non-significant). Conclusions In unstable coronary artery disease, STsegment depression is associated with a 1% increase in the occurrence of three-vessel/left main disease and to an increased risk of subsequent cardiac events. In these patients an early invasive strategy substantially decreases death/myocardial infarction. (Eur Heart J 22; 23: 41 49, doi:1.153/euhj ) 21 The European Society of Cardiology Key Words: Unstable angina, coronary angiography, coronary angioplasty, coronary bypass, electrocardiography, myocardial infarction. See page 3, doi:1.153/euhj for the Editorial comment on this article Introduction The clinical diagnosis of unstable coronary artery disease is based on the occurrence of unstable angina or a non-st-segment-elevation myocardial infarction. This group of patients is heterogeneous and the prognosis Revision submitted 14 March 21, accepted 21 March 21, and published online 21 August 21. Correspondence: Erik Diderholm, MD, Department of Cardiology, Cardiothoracic Center, University Hospital, S Uppsala, Sweden X/2/141+9 $35./ varies considerably. Patients with ST-segment depression in the electrocardiogram (ECG) on admission have a markedly increased risk for future cardiac events compared with those without ST-segment depression [1 1]. So far no randomized trial has evaluated whether STsegment and T wave changes could identify patients with a specific response to early revascularization. The FRISC II trial compared an early invasive with a non-invasive strategy regarding death and myocardial infarction in unstable coronary artery disease [11]. After 12 months there were reductions in death, myocardial infarction as well as in late revascularization and need 21 The European Society of Cardiology
2 42 E. Diderholm et al. for readmission [12]. The objective of this study was to evaluate whether the effect of the invasive strategy was related to the occurrence and type of ST-segment and T- wave changes in the ECG on admission. In addition, we evaluated the relationship between different ST-segment and T wave changes in the ECG at entry and outcome in the non-invasive group and the extent of coronary lesions in the invasive group. Methods Patients In the Fast Revascularisation in InStability in Coronary disease trial (FRISC II) 2457 patients were randomized to an invasive or a non-invasive regimen [11,12]. Patients with unstable angina or non-st-segment-elevation myocardial infarction were eligible for the trial. Inclusion criteria were symptoms of cardiac ischaemia associated with either ST-segment depression 1 mv, or T-wave inversion 1 mv in at least one lead, or elevation of biochemical markers indicating myocardial damage. The study complied with the Declaration of Helsinki and all local ethics committees approved the protocol. chest pain, a diagnostic ECG or elevation of biochemical markers of myocardial damage [11]. Only new Q waves were used for the diagnosis of myocardial infarction in association with coronary artery bypass grafting (CABG). Coronary angiography All coronary angiograms performed within 6 months were evaluated locally and recorded in a standardized format. The coronary vessels were divided into 16 segments, four from the right coronary artery, five from the left anterior descending artery diagonal branches, 4 6 from the left circumflex artery obtuse marginal branches and one from the left main coronary artery, in accordance with the AHA committee report on coronary artery disease from 1975 [13]. The degree of stenosis (%) in each of these 16 segments was evaluated into one of five degrees (, <5, 5 7, >7 or 1=occlusion). A 5% stenosis in at least one of the segments in the respective vessel area (right coronary artery, left anterior descending diagonal and circumflex obtuse marginal) was considered significant in respect of the traditional one-, two- and three-vessel disease. For the left main artery, a 5% stenosis was considered significant. Randomized treatment The patients gave informed, written consent and were randomized, using a 2 2 factorial design, to an early invasive or early non-invasive strategy and to short-term or long-term treatment with dalteparin. In the early invasive group, coronary angiography and, if appropriate, revascularization was to be performed within 7 days. Revascularization was recommended in all patients with r7% diameter obstruction in any artery supplying a significant proportion of the myocardium. In the non-invasive group, coronary angiography/ revascularization was recommended in cases of severe angina, severe ischaemia at a pre-discharge exercise test or (new) myocardial infarction [11]. All patients received open label dalteparin for at least 5 days and always until a scheduled revascularization procedure. Thereafter the patients continued on longterm treatment with dalteparin or placebo. As long-term dalteparin treatment had no significant effect on the 12-month outcome, the dalteparin and placebo groups have been combined in the present report. Follow-up and end-points Patients were followed by outpatient visits for 6 months [11]. The 12-month follow-up was performed by telephone interview and, if appropriate, by evaluation of the patient s hospital record [12]. Myocardial infarction was based on the presence of two out of the conventional three criteria, i.e. typical ECG substudy The admission ECG was evaluated at a core laboratory, which was unaware of the patients randomization and clinical outcome. ST-segment depression was considered present if it was horizontal or down-sloping and at least 5 mv. Inverted T wave(s) was considered present if the T wave was isoelectric, negative or biphasic in leads V 3 V 6, avl (if R> 5 mv), I and II. At least 1 mv T-wave inversion was required in leads V 2 and avf (positive QRS also required). In V 1, avr and III T waves were not evaluated. Statistics The statistical evaluation was performed on an intention-to-treat basis. The efficacy analyses were point estimates and only included patients with an adjudicated event or with recorded absence of the evaluated event until at least 335 days of follow-up. Differences between categorical variables were analysed for significance by the Pearson chi-squared test with results presented as risk ratios with 95% confidence intervals. As regards continuous variables, the ANOVA model was used to assess significance of differences. Kaplan Meier 1-survival plots were used to illustrate the timing of events without any analysis of significance. The importance of ST-segment depression was further evaluated with multivariate logistic regression. The interaction between the occurrence of ST-segment depression and the invasive strategy was used in the
3 The FRISC II ECG substudy 43 Table 1 Baseline characteristics in relation to ST-segment and T wave changes in admission ECG ST depression Isolated inverted T No STT changes P n Mean age (years) < 1 Males < 1 Non-smokers ns Hypertension < 1 Cholesterol 5 5 mmol.l 1 * ns Diabetes mellitus ns Previous myocardial infarction < 1 Angina >3 months < 1 Troponin T 1 μg.l < 1 LVEF <45% < 1 Values are percentages unless otherwise indicated. *213 mg.dl 1. Pearson chi-squared test comparing all three ECG groups. LVEF=Left ventricular ejection fraction (echocardiography). regression model. The data processing and statistical analyses were performed using the SPSS 1. statistical program. Results ST-segment and T wave changes in admission ECG The admission ECG was available in 2446 (99 6%) patients. Evaluation of ischaemia via an ECG was not possible in 38 (1 6%) patients, who were excluded from the analyses. ST-segment depression occurred in 1114 (45 5%) patients, isolated T-wave inversion was found in 871 (35 6%) and 423 (17 3%) had no ST-segment and T wave changes. Baseline characteristics in relation to ST-segment and T wave changes There were considerable differences in baseline characteristics between the three groups (Table 1). The patients with ST-segment depression were older and more often had angina pectoris and hypertension. The group with no ST-segment and T wave changes was younger and contained fewer female and patients with previous myocardial infarction. Among patients with any ST-segment and T wave change, 14% had reduced left ventricular function compared with 5 6% in those without STsegment and T wave changes. There were no significant differences in baseline characteristics within the three ECG groups between those randomized to early invasive or non-invasive strategies. Coronary lesions and revascularization procedures in relation to ST-segment and T wave changes in the invasive group Coronary angiography was performed within 7 days in 96% and within 6 months in 98% of patients. There were considerable differences between the ECG subgroups regarding the extent of coronary artery disease (Fig. 1). In the group with ST depression there were significantly more patients with three-vessel or left main disease, 45% compared with 22% if no ST-segment depression was present, RR 2 1 (CI ) P< 1. Almost 2% of the patients without ST-segment depression on admission had no significant stenosis compared with fewer than 1% if ST-segment depression was present. The extent of angiographic coronary artery disease was similar in the groups with isolated T-wave inversion and no ST-segment and T wave changes. There were significantly more revascularization procedures in patients with ST-segment depression compared to the other two groups (Table 2). This difference was caused by significantly more CABG interventions, 48% if ST-segment depression was present compared with 28% in those without ST-segment depression. The corresponding numbers for PTCA were 37% and 45%, respectively, which also was a statistically significant difference. Coronary lesions and cardiac event rates in relation to ST-segment and T wave changes, in the non-invasive group In the non-invasive group, patients with ST-segment depression more often needed coronary angiography, 55% within 6 months, compared with those with isolated T-wave inversion (44%) and when no ST-segment and
4 44 E. Diderholm et al % No STT changes n = 218 Isolated T inv n = 427 ST depression n = 529 Figure 1 Extent of coronary artery disease at angiography in relation to ST-segment and T wave (STT) changes on admission, invasive cohort only. =no significant stenosis;,, =one-, two- and three-vessel disease; =left main disease, inv=inversion. Table 2 Number of revascularization procedures (%) within 12 months in relation to ST-segment and T wave changes on admission and randomization ST-segment and T wave change and randomization n Revasc % CABG % PTCA % Non-invasive ST depression * 3* 21 Isolated inverted T waves No STT changes 24 29* 11* 18 Invasive ST depression * 48* 37 Isolated inverted T waves No STT changes * 5* Revasc=revascularization. CABG=coronary artery bypass grafting. PTCA=percutaneous transluminal coronary angioplasty. STT=ST-segment and T wave changes. *P< 5 compared to the group with isolated inverted T waves. If both CABG and PTCA are performed, it is referred to as CABG. T wave change was present (35%). Among those in whom angiography was performed there was also more three-vessel or left main disease in patients with STsegment depression compared with the other groups: 5, 31 and 29%, respectively. Patients with no ST-segment and T wave changes had a risk of death/myocardial infarction after 12 months similar to patients with isolated T-wave inversion: 1 3% and 1 5%, respectively. However, in patients with STsegment depression the event rate was 18 2%, RR 1 75 (CI ), P< 1 compared with patients without ST-segment depression (Fig. 2). Even at 12- month mortality the risk was higher at ST-segment depression (5 8%) compared with those without STsegment depression (2 %), RR 2 86 (CI ), P= 1. The number of revascularization procedures in the non-invasive group was significantly related to the STsegment and T wave changes on admission. Thus, within 12 months 51% of those with ST-segment depression compared with 39% with isolated T-wave inversion and 29% without ST-segment and T wave changes had undergone coronary procedures (Table 2 and Fig. 3). PTCA was performed in about 2% of the patients without any difference between the three ECG groups. Thus, the difference in coronary procedures between the groups was explained by different rates of CABG (Table 2).
5 The FRISC II ECG substudy 45 Probability of death or myocardial infarction ST depression n = 571 P < 1 No STT changes n = 24 Isolated T wave inversion n = Days Figure 2 Probability of death or myocardial infarction in relation to ST-segment and T wave (STT) changes on admission in the non-invasive cohort only, illustrated by Kaplan Meier (1-survival) plots. The P value is evaluated by chi-squared analysis as a point estimate at 12 months and refers to the difference in outcome between patients with and without ST-segment depression Probability of revascularization ST depression n = 571 P < 1 Isolated T inversion n = 439 No STT change n = 24 P < Days Figure 3 Probability of revascularization in relation to ST-segment and T wave (STT) changes on admission in the non-invasive cohort only, illustrated by Kaplan Meier (1-survival) plots. The P values are evaluated by chi-squared analysis as point estimates at 12 months comparing the group with isolated T-wave inversion with the other two. 36 Effect of the invasive vs the non-invasive strategy in relation to ST-segment and T wave changes In patients with ST-segment depression the invasive strategy reduced the 12-month rate of death/myocardial infarction from 18 2% to 12 % (Table 3, Fig. 4). Even the death rate alone, after 12 months, tended to be reduced, from 5 8% to 3 3%, by the invasive strategy in the ST-segment depression cohort (Table 3, Fig. 5). The groups with no ST-segment and T wave changes and isolated T-wave inversion were similar concerning prognosis and angiographic extent of coronary artery
6 46 E. Diderholm et al. Table 3 Death, death or myocardial infarction, and readmission within 12 months and occurrence of angina pectoris at 3 months, in the invasive and non-invasive strategy in relation to occurrence of ST-segment depression in admission ECG Patients Inv/non-inv n/n Invasive n(%) Events Non-invasive n(%) RR (95% CI)* P ST-segment depression Death 542/ (3 3%) 33 (5 8%) 58 ( ) 5 Death or MI 54/ (12 %) 14 (18 2%) 66 ( 5 88) 4 Readmission within 12 months 54/ (38%) 35 (61%) 63 ( 56 71) < 1 Angina 3 months 518/ (18%) 236 (44%) 42 ( 34 51) < 1 No ST-segment depression Death 651/643 8 (1 2%) 13 (2 %) 61 ( ) 26 Death or MI 65/ (8 9%) 67 (1 4%) 86 ( ) 36 Readmission within 12 months 65/ (35%) 342 (53%) 67 ( 59 76) < 1 Angina 3 months 633/ (22%) 272 (43%) 52 ( 44 62) < 1 Inv/non-inv=invasive/non-invasive. MI=myocardial infarction. *Risk ratios (RR) and 95% confidence intervals refer to the comparison between the effect of the invasive and the non-invasive strategies. 2 Probability of death or myocardial infarction Non-invasive (n = 571) P < 1 Invasive (n = 54) Non-invasive (n = 643) Invasive (n = 65) ST dep No ST dep Days Figure 4 Probability of death or myocardial infarction in relation to strategy and occurrence of ST-segment depression on admission, illustrated by Kaplan Meier (1-survival) curves. The P value is evaluated by chi-squared analysis as a point estimate at 12 months and refers to the difference in outcome between invasive and non-invasive strategies. ST dep=st-segment depression. 36 disease. In the analyses of relationship to outcome they were therefore merged into one group. Death/ myocardial infarction at 12 months in patients without ST-segment depression occurred in 8 9% of the invasive group compared with 1 4% in the non-invasive group (P=ns). In patients with as well as without ST-segment depression, the early invasive strategy was associated with a reduction in readmissions and angina pectoris at follow-up (Table 3). Multivariate analysis The importance of ST depression and invasive strategy were evaluated by multivariate logistic regression in terms of risk of death/myocardial infarction after 12 months. The following clinical parameters were adjusted for in the analysis: age, gender, smoking, hypertension, cholesterol 5 5 mmol.l 1, diabetes, previous myocardial infarction, Troponin T value
7 The FRISC II ECG substudy 47 6 Non-invasive (n = 571) 5 P = 5 ST dep Probability of death Invasive (n = 542) Non-invasive (n = 643) No ST dep 1 Invasive (n = 651) Days Figure 5 Probability of death in relation to strategy and occurrence of ST-segment depression on admission, illustrated by Kaplan Meier (1-survival) curves. The P value is evaluated by chi-squared analysis as a point estimate at 12 months and refers to the difference in outcome between invasive and non-invasive strategies. ST dep=st-segment depression μg.l 1 at randomization and the 3 months doubleblind treatment (dalteparin or placebo). In the total data set, ST-segment depression remained an independent risk factor for death/myocardial infarction after 12 months (Table 4). In the non-invasive group, STsegment depression was an independent risk factor for death/myocardial infarction at 12 months, RR 1 58 ( ) P= 14. In contrast, in the invasive group ST-segment depression did not turn out as a significant independent risk factor, RR 1 32 ( 88 2 ) P= 18. In the total data set we also evaluated whether there was any interaction between the occurrence of STsegment depression and the invasive strategy on death or myocardial infarction. However in the multivariate logistic regression analysis, also including ST-segment depression, invasive strategy and the product of these two factors, no significant interaction was found (P= 37). Table 4 Multivariate logistic regression analysis of the predictive value of ST depression on admission and of the effect of an early invasive strategy for death/myocardial infarction at 12 months after adjustment for other clinical factors* n RR (95% CI) P ST-segment depression ( ) 8 Invasive strategy ( 52 88) 4 *Adjusted for age, gender, smoking, hypertension, cholesterol 5 5 mmol.l 1, diabetes, previous myocardial infarction, Troponin T value 1 μg.l 1 at randomization and the 3 months double-blind treatment (dalteparin or placebo). Risk ratios and 95% confidence interval. Discussion In the present study the randomization of early coronary angiography gave a unique opportunity to evaluate the relationship between ECG changes and the extent of coronary lesions in 98% of the patients treated invasively. The occurrence of ST-segment depression was associated with three-vessel disease in 32% and left main stenosis in 13%. In the 55% of the patients with ST-segment depression in the non-invasive group who, because of ischaemia, were investigated by coronary angiography during the first 6 months, the rates of three-vessel or left main disease were similar, 4% and 1%, respectively. Thus, at ST-segment depression almost half of the patients with three-vessel or left main disease had not been identified within the first 6 months with the noninvasive approach. The occurrence of three-vessel disease in the ST-segment depression cohort of our study was in accord with the GUSTO IIB study [3] where 56% of patients with ST-segment depression had an angiogram, out of which 36% had three-vessel disease. In unstable coronary artery disease, a number of studies have shown the increased risk for subsequent events in patients presenting with ST-segment depression in the ECG at rest [1 1]. If isolated T-wave inversion is present the risk is lower [2 4,1]. The high risk in patients with ST-segment depression is to some extent caused by the fact that these patients have other risk factors, e.g. older age, angina, hypertension and previous myocardial infarction compared with those without ST-segment depression. However, in this as in previous studies multivariate analyses demonstrated that ST-segment depression is an independent risk factor for future cardiac events [2 4,7 1].
8 48 E. Diderholm et al. The prognostic importance of isolated T-wave inversion is more difficult to assess and the results from previous studies are conflicting. In some cases, especially if located in precordial leads, the isolated inverted T waves might reflect a severe proximal left anterior descending stenosis [14,15]. However, many patients with isolated inverted T waves have no coronary stenosis. In the GUSTO IIB study 19% of patients with isolated inverted T waves had no significant stenosis [3], which is in good agreement with the 16% in the total data set of the present study. In ours as in other [4,5] studies, patients with isolated inverted T waves had a similar risk of death or myocardial infarction at 1 year as those with no ST-segment and T wave changes. However, it needs to be emphasized that due to inclusion criteria in our study, patients without ST-segment and T wave changes had to have increased cardiac markers. Early revascularization has been suggested for unstable patients at moderate or high risk. However, FRISC II was the first randomized trial to demonstrate that an early invasive strategy significantly reduced deaths or myocardial infarctions, after 12 months, from 14 1 to1 4%, and mortality from 3 9 to2 2% [12].Inthe present analyses it was demonstrated that the early invasive strategy has a remarkable effect in patients with ST-segment depression at entry: death or myocardial infarction after 12 months was reduced from 18 2 to 12 % (P= 4), and in the numeric reduction mortality was from 5 8 to 3 3% (P= 5). The pronounced effect in the ST-segment depression group was also illustrated by the loss of the independent relationship between ST-segment depression and outcome in the invasive cohort. No previous trial has been able to show such a dramatic reduction in events in this group of patients. To our knowledge, this is the first study demonstrating that ECG changes, in addition to being prognostic, can be used to choose treatment to reduce death/myocardial infarction in unstable coronary syndromes. Among the patients with ST-segment depression, a large proportion were revascularized with CABG because of the common occurrence of threevessel or left main disease. Thus, the better outcome, and especially the lower mortality in the invasive arm in the ST-segment depression cohort, might be related to the well-established life saving effect of CABG in threevessel or left main disease [16]. Patients without STsegment depression had the advantage of an early invasive strategy, although the reduction in death or myocardial infarction was not significant, perhaps because of the lower event rates. However, there were comparable 3 5% reductions in readmissions and symptoms of angina pectoris during follow-up as well in patients without as well as with ST-segment depression. In this substudy, we used a cut-off level of 5 mv for ST-segment depression; in previous studies this measure has been associated with increased risk of future cardiac events [2,1]. However, inclusion criteria for the FRISC II study which, except for randomization to the early invasive strategy, also included 3 months twice daily subcutaneous dalteparin/placebo, were more strict, and at least 1 mv ST-segment depression was needed. This means that the results in patients with ST-segment depression in the present study might not necessarily be applicable to patients presenting with less than 1 mv of ST-segment depression, unless T-wave inversion or a rise in biochemical marker levels is also present. The degree of ST-segment depression is correlated to worsening outcome [1]. In this study, however, ST-segment depression was used as a dichotomous variable. Thus, we have not analysed whether the degree of ST-segment depression would provide further information on the effects of the invasive treatment. Another possible limitation of the study is the definition of myocardial infarction in association with CABG in which only new Q waves were referred to as myocardial infarction. This could be one reason for the more beneficial effect in patients with ST-segment depression where CABG was more common. However, this hypothesis is contradicted by the similar change in mortality and myocardial infarction by early invasive strategy in patients with ST-segment depression. Conclusions In unstable coronary artery disease, patients with STsegment depression on admission have a high proportion of three-vessel or left main disease and, although treated with aspirin and at least 5 days of low molecular weight heparin, an almost doubled risk for future cardiac events including a 6% 1-year mortality. In these patients an early invasive strategy, on top of the above antithrombotic treatment, was associated with a relative reduction of 42% in mortality, 34% in death/myocardial infarction at 1 year and, in addition, a 3 5% reduction in symptoms of angina pectoris and readmissions. Despite the fact that at least half of the patients with ST-segment depression will need revascularization during the following year, half of the patients with threevessel or left main disease will remain undetected with a primarily non-invasive strategy. Therefore, in unstable coronary artery disease with ST-segment depression in ECG at rest, an early invasive approach has a very high priority. The study was supported by and organized in collaboration with the Pharmacia & Upjohn Company. The project organization within the research group was also supported by the Swedish Heart-Lung Foundation. We gratefully acknowledge the invaluable contribution of all patients who agreed to participate and the dedicated work of the research nurses, monitors, investigators, co-ordinators, core laboratories, end-point-committee and data safety monitoring board. References [1] Nyman I, Areskog M, Areskog NH, Swahn E, Wallentin L. Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease. The RISC Study Group. J Intern Med 1993; 234: [2] Cannon CP, McCabe CH, Stone PH et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-q wave myocardial infarction: results of the
9 The FRISC II ECG substudy 49 TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997; 3: [3] Savonitto S, Ardissino D, Granger CB et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999; 281: [4] Holmvang L, Clemmensen P, Wagner G, Grande P. Admission standard electrocardiogram for early risk stratification in patients with unstable coronary artery disease not eligible for acute revascularization therapy: a TRIM substudy. ThRombin Inhibition in Myocardial Infarction. Am Heart J 1999; 137: [5] Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-q-wave myocardial infarction in predicting outcome. Am J Cardiol 1991; 67: [6] Patel DJ, Holdright DR, Knight CJ et al. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996; 75: [7] Haim M, Benderley M, Hod H, Reicher-Reiss H, Goldbourt U, Behar S. The outcome of patients with a first non-q wave acute myocardial infarction presenting with ST segment depression, ST segment elevation, or no ST deviations on the admission electrocardiogram. Int J Cardiol 1998; 67: [8] Schechtman KB, Capone RJ, Kleiger RE et al. Risk stratification of patients with non-q wave myocardial infarction. The critical role of ST segment depression. The Diltiazem Reinfarction Study Research Group. Circulation 1989; 8: [9] Krone RJ, Greenberg H, Dwyer EM, Jr., Kleiger RE, Boden WE. Long-term prognostic significance of ST segment depression during acute myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. J Am Coll Cardiol 1993; 22: [1] Hyde TA, French JK, Wong CK, Straznicky IT, Whitlock RM, White HD. Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of.5-mm ST-segment depression. Am J Cardiol 1999; 84: [11] Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 354 (918): [12] Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2; 356 (9223): [13] Austen WG, Edwards JE, Frye RL et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51 (4 Suppl): 5 4. [14] Haines DE, Raabe DS, Gundel WD, Wackers FJ. Anatomic and prognostic significance of new T-wave inversion in unstable angina. Am J Cardiol 1983; 52: [15] de Zwaan C, Bar FW, Wellens HJ. Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. Am Heart J 1982; 13 (4 Pt 2): [16] Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 1-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344 (8922):
Journal of the American College of Cardiology Vol. 41, No. 6, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 41, No. 6, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)02970-4
More informationQuantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population
European Heart Journal (2005) 26, 112 118 doi:10.1093/eurheartj/ehi026 Clinical research Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II
More informationBecause patients with non ST-segment elevation acute
Prognostic Value of Lead avr in Patients With a First Non ST-Segment Elevation Acute Myocardial Infarction José A. Barrabés, MD; Jaume Figueras, MD; Cristina Moure, MD; Josefa Cortadellas, MD; Jordi Soler-Soler,
More informationJournal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00643-9 Early
More informationTIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS
European Heart Journal (2005) 26, 865 872 doi:10.1093/eurheartj/ehi187 Clinical research TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS
More informationBelinda Green, Cardiologist, SDHB, 2016
Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens
More informationJournal of the American College of Cardiology Vol. 41, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 41, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)02824-3
More informationJournal of the American College of Cardiology Vol. 40, No. 6, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 40, No. 6, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02119-8
More informationST Segment Depression in 12 lead ECG and Severity of Coronary Artery Disease in Non-ST segment elevation Acute Coronary Syndrome
ST Segment Depression in 12 lead ECG and Severity of Coronary Artery Disease in Non-ST segment elevation Acute Coronary Syndrome Mohammad Emdadul Hoque Miah 1, Abul Hussain Khan Chowdhury 2, Khandaker
More informationP atients with unstable angina or non-st elevation myocardial
36 CARDIOVASCULAR MEDICINE Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers S Kennon, C P Price, P G Mills, P K MacCallum, J Cooper, J Hooper,
More informationPatient characteristics Intervention Comparison Length of followup
ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing
More informationInter-regional differences and outcome in unstable angina
European Heart Journal (2000) 21, 1433 1439 doi:10.1053/euhj.1999.1983, available online at http://www.idealibrary.com on Inter-regional differences and outcome in unstable angina Analysis of the International
More informationTreatment strategies and risk stratification in acute coronary syndromes Damman, P.
UvA-DARE (Digital Academic Repository) Treatment strategies and risk stratification in acute coronary syndromes Damman, P. Link to publication Citation for published version (APA): Damman, P. (2013). Treatment
More informationCase Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA
Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after
More informationThe role of the initial 12-lead ECG in risk stratification of patients with acute coronary syndrome
406 Bratisl Lek Listy 2001; 102 (9): 406-411 TOPICAL REVIEW The role of the initial 12-lead ECG in risk stratification of patients with acute coronary syndrome Schweitzer P, Keller S Heart Institute, Beth
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram Ben-Gal T, Zafrir
More informationATHEROSCLEROSIS IS CHARACterized
ORIGINAL CONTRIBUTION Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease Effects of an Early Invasive or Noninvasive Eva Lindmark, MMed Erik Diderholm, MD
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationIN patients with ST elevated myocardial infarction, ST segment resolution following
The Effect of Tirofiban on ST Segment Resolution in Patients With Non-ST Elevated Myocardial Infarction Özgür BAYTURAN, 1 MD, Ali Riza BILGE, 1 MD, Cevad SEKÜRI, 1 MD, Ozan ÜTÜK, 1 MD, Hakan TIKIZ, 1 MD,
More informationPatient referral for elective coronary angiography: challenging the current strategy
Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationQUT Digital Repository:
QUT Digital Repository: http://eprints.qut.edu.au/ This is the author s version of this journal article. Published as: Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes.
More informationAcute Myocardial Infarction: Difference in the Treatment between Men and Women
Quality Assurance in Hcahh Can, Vol. 5, No. 3, pp. 261-265,1993 Printed in Great Britain 1040-6166/93 $6.00 + 0.00 1993 Pergamon Press Ltd Acute Myocardial Infarction: Difference in the Treatment between
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationMulti-Lead ST-Monitoring in the Early Assessment of Patients with Suspected or Confirmed Unstable Coronary Artery Disease
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 966 Multi-Lead ST-Monitoring in the Early Assessment of Patients with Suspected or Confirmed Unstable Coronary Artery Disease
More informationUPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18
UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment
More informationThe Thrombolysis In Myocardial Infarction Risk Score in Unstable Angina/ Non ST-Segment Elevation Myocardial Infarction
Journal of the American College of Cardiology Vol. 41, No. 4 Suppl S 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)03019-x
More informationOriginal Article Impact of timing to coronary angiography in acute coronary syndrome on contemporary clinical practice
Am J Cardiovasc Dis 2012;2(3):248-252 www.ajcd.us /ISSN:2160-200X/AJCD1204002 Original Article Impact of timing to coronary angiography in acute coronary syndrome on contemporary clinical practice Angela
More informationJournal of the American College of Cardiology Vol. 39, No. 10, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 39, No. 10, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01841-7
More informationCritical Review Form Therapy Objectives: Methods:
Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To
More informationPlatelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes
European Heart Journal (00) 3, 1441 1448 doi:10.1053/euhj.00.3160, available online at http://www.idealibrary.com on Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes Gradient of benefit
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationProspective Comparison of Hemorrhagic Complications After Treatment With Enoxaparin
Prospective Comparison of Hemorrhagic Complications After Treatment With Versus Unfractionated Heparin for Unstable Angina Pectoris or Non ST-Segment Elevation Acute Myocardial Infarction Scott D. Berkowitz,
More informationInfluence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence
More informationCardiac Troponin I Levels and Clinical Outcomes in Patients With Acute Coronary Syndromes The Potential Role of Early Percutaneous Revascularization
Journal of the American College of Cardiology Vol. 34, No. 6, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00434-9 Cardiac
More informationGrowth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome Kai C. Wollert, Tibor Kempf, Bo Lagerqvist, Bertil Lindahl,
More informationTo estimate the serum level of N-terminal pro-brain natriuretic peptide levels in acute coronary syndrome
Original Research Article To estimate the serum level of N-terminal pro-brain natriuretic peptide levels in acute coronary syndrome Mohamed Yasar Arafath 1, K. Babu Raj 2* 1 First Year Post Graduate, 2
More informationCardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status
European Heart Journal (2000) 21, 1159 1166 doi:10.1053/euhj.1999.1986, available online at http://www.idealibrary.com on Cardiovascular risk and therapeutic benefit of coronary interventions for patients
More informationImpact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,
More informationManagement of ST-elevation myocardial infarction Update 2009 Late comers: which options?
European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth
More informationJoakim Alfredsson, Johan Lindbäck, Lars Wallentin and Eva Swahn. Linköping University Post Print
Similar outcome with an invasive strategy in men and women with non-st-elevation acute coronary syndromes From the Swedish Web- System for Enhancement and Development of Evidence-Based Care in Heart Disease
More informationNstemi But Stemi-De Winters Sign
Cardiology and Angiology: An International Journal 3(3): 162-166, 2015, Article no.ca.2015.015 ISSN: 2347-520X SCIENCEDOMAIN international www.sciencedomain.org Nstemi But Stemi-De Winters Sign Prem Krishna
More informationSupplementary Material to Mayer et al. A comparative cohort study on personalised
Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationRisk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium
Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationPlasma levels of cardiac troponin (ctn) provide important
Elevated Troponin I Level on Admission Is Associated With Adverse Outcome of Primary Angioplasty in Acute Myocardial Infarction Shlomo Matetzky, MD; Tali Sharir, MD; Michelle Domingo, BS; Marko Noc, MD;
More informationOUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
More informationHospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension
(2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with
More informationA CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES
A CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES Niyamtullah Musalman 1*, Lijun Jin 2 and Farhan Khan 3 *12 Department of Cardiology, Yangtze Medical University
More informationTCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI
Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi
More information2003 by the American College of Cardiology Foundation ISSN /03/$30.00
Journal of the American College of Cardiology Vol. 41, No. 4 Suppl S 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)02963-7
More informationNew Risk Score for Patients With Acute Chest Pain, Non ST-Segment Deviation, and Normal Troponin Concentrations A Comparison With the TIMI Risk Score
Journal of the American College of Cardiology Vol. 46, No. 3, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.04.037
More informationCronicon CARDIOLOGY. N Laredj*, HM Ali Lahmar and L Hammou. Abstract
Cronicon OPEN ACCESS CARDIOLOGY Research Article Persistent Ischemia in Recovery Predicts Mortality after Myocardial Infarction in Patients Undergoing Dobutamine N Laredj*, HM Ali Lahmar and L Hammou Department
More informationMARKERS OF MYOCARDIAL DAMAGE AND INFLAMMATION IN RELATION TO LONG-TERM MORTALITY
MARKERS OF MYOCARDIAL DAMAGE AND INFLAMMATION IN RELATION TO LONG-TERM MORTALITY IN UNSTABLE CORONARY ARTERY DISEASE BERTIL LINDAHL, M.D., PH.D., HENRIK TOSS, M.D., AGNETA SIEGBAHN, M.D., PH.D., PER VENGE,
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationJournal of the American College of Cardiology Vol. 38, No. 4, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01503-0 Acute
More informationImaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference
More informationSetting The setting was secondary care. The economic study was carried out in the USA.
Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris Desai A S, Solomon D H, Stone P H, Avorn J Record Status This is a critical abstract
More informationARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial
ARMYDA-RECAPTURE ( for Reduction of MYocardial Damage during Angioplasty) trial Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic
More informationPreface: Wang s Viewpoints
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part IV, Ischemia and Infarction Presented by: WANG, TZONG LUEN, MD, PhD, JM, FACC, FESC, FCAPSC Professor,
More informationFFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators
FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of
More informationBMJ Open. Does T wave inversion in lead avl predict mid-segment left anterior descending lesion in acute coronary syndrome?
Does T wave inversion in lead avl predict mid-segment left anterior descending lesion in acute coronary syndrome? Journal: Manuscript ID bmjopen-0-00 Article Type: Research Date Submitted by the Author:
More informationRole of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University
Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without
More informationTiming of angiography for high- risk ACS
Timing of angiography for high- risk ACS Christian Spaulding, MD, PhD, FESC, FACC Cardiology Department Cochin Hospital, Inserm U 970 Paris Descartes University Paris, France A very old story. The Interventional
More informationDisclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None
Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines
More informationTiming of intervention in high-risk non-st-elevation acute coronary syndromes in PCI versus non-pci centres
DOI 10.1007/s12471-015-0801-7 Original Article Timing of intervention in high-risk non-st-elevation acute coronary syndromes in PCI versus non-pci centres Sub-group analysis of the ELISA-3 trial E.A. Badings
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationSKG Congress, 2015 EVOLVE II. Stephan Windecker
SKG Congress, 2015 EVOLVE II Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland BIODEGRADABLE POLYMER DES Stefanini,
More informationPrimary PCI versus thrombolytic therapy: long-term follow-up according to infarct location
Heart Online First, published on April 14, 2005 as 10.1136/hrt.2005.060152 1 Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Short running head: Anterior infarction
More informationThe Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial
Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non ST-Elevation Acute Coronary Syndrome The Clopidogrel in Unstable angina to prevent
More informationCoronary Artery Disease: Revascularization (Teacher s Guide)
Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention
More informationEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden
More informationOtamixaban for non-st-segment elevation acute coronary syndrome
Otamixaban for non-st-segment elevation acute coronary syndrome September 2011 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationΣεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική
ΕΛΛΗΝΙΚΗΚΑΡΔΙΟΛΟΓΙΚΗΕΤΑΙΡΕΙΑ Σεμινάριο Ομάδων Εργασίας 2011 Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική GUIDELINES ON MYOCARDIAL
More informationManagement of stable CAD FFR guided therapy: the new gold standard
Management of stable CAD FFR guided therapy: the new gold standard Suleiman Kharabsheh, MD Director; CCU, Telemetry and CHU Associate professor of Cardiology, Alfaisal Univ. KFHI - KFSHRC Should patients
More informationThe updated guidelines from the National
BEYOND NCEP ATP III: LESSONS LEARNED AND FUTURE DIRECTIONS * Benjamin J. Ansell, MD, FACP ABSTRACT The National Cholesterol Education Program (NCEP) Third Adult Treatment Panel (ATP III) guidelines provide
More informationEARLY, NON-INVASIVE PREDICTORS OF LEFT MAIN OR 3- VESSEL DISEASE IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
EARLY, NON-INVASIVE PREDICTORS OF LEFT MAIN OR 3- VESSEL DISEASE IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME Mohammad H. Alshari, Montaser M. Alcekelly, Mohammad M. Al-Daydamony and
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationBiphasic T-wave in patient with chest pain (Wellens syndrome)
www.edoriumjournals.com CLINICAL IMAGES PEER REVIEWED OPEN ACCESS Biphasic T-wave in patient with chest pain (Wellens syndrome) Ahmed Zedan, Osama Mukarram, Umer Malik, Raja Naidu ABSTRACT Abstract is
More informationA Report From the Second National Registry of Myocardial Infarction (NRMI-2)
1240 JACC Vol. 31, No. 6 Clinical Experience With Primary Percutaneous Transluminal Coronary Angioplasty Compared With Alteplase (Recombinant Tissue-Type Plasminogen Activator) in Patients With Acute Myocardial
More informationECG in coronary artery disease. By Sura Boonrat Central Chest Institute
ECG in coronary artery disease By Sura Boonrat Central Chest Institute EKG P wave = Atrium activation PR interval QRS = Ventricle activation T wave= repolarization J-point EKG QT interval Abnormal repolarization
More informationComplete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report
J Cardiol 2004 Nov; 44 5 : 201 205 Complete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report Takatoshi Hiroshi Akira Takahiro Masayasu
More informationRational use of imaging for viability evaluation
EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium
More informationReciprocal ST depression in acute myocardial infarction
Reciprocal ST depression in acute myocardial infarction Br Heart J 1985; 54: 479-83 OLUSOLA ODEMUYIWA, IAN PEART, CATHERINE ALBERS, ROGER HALL From the Royal Victoria Infirmary, Newcastle upon Tyne SUMMARY
More informationThe Angiotensin-converting Enzyme Inhibition Post Revascularization
Journal of the American College of Cardiology Vol. 35, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00634-8 CLINICAL
More informationHow should patients with unstable angina and non-stsegment elevation myocardial infarction be managed? A meta-analysis of randomized trials
The American Journal of Medicine (2005) 118, 465 474 REVIEW How should patients with unstable angina and non-stsegment elevation myocardial infarction be managed? A meta-analysis of randomized trials Niteesh
More informationCLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA
RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationA cute coronary syndrome (ACS) is a broad
217 REVIEW Contemporary management of acute coronary syndrome G A Large... This review focuses on the modern management of the non- ST elevation acute coronary syndromes (unstable angina and non-st elevation
More informationChest Pain: To Cath or Not? Part I
Chest Pain: To Cath or Not? Part I Georgios Papaioannou, MD Ioannis Karavas, MD Newton-Wellesley Hospital 5/3/2000 1 A Typical Scenario... 57 year old female, Mrs. X., presents to your office with a 2
More informationPrediction of the Site of Coronary Artery Lesion in Acute Inferior Myocardial Infarction with Right Sided Precordial Lead (V4r)
Prediction of the Site of Coronary Artery Lesion in Acute Inferior Myocardial Infarction with Right Sided Precordial Lead (V4r) MS Alam, M Ullah, SU Ulabbi, MM Haque, R Uddin, MS Mamun, AAS Majumder National
More informationAdults With Diagnosed Diabetes
Adults With Diagnosed Diabetes 1990 No data available Less than 4% 4%-6% Above 6% Mokdad AH, et al. Diabetes Care. 2000;23(9):1278-1283. Adults With Diagnosed Diabetes 2000 4%-6% Above 6% Mokdad AH, et
More informationTopic. Updates on Definition of Myocardial Infarction
Topic Updates on Definition of Myocardial Infarction In the past, general consensus for MI? Definition of MI by WHO - Combination of 2 of 3 characteristics - 1. Typical Symptoms 2. Enzyme Rise 3. Typical
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial
compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationF or a long time the 12-lead electrocardiogram
490 REVIEW The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis Y Birnbaum, B J Drew... The electrocardiogram is considered an essential part
More informationEffects of Statins on Endothelial Function in Patients with Coronary Artery Disease
Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,
More information